TEL AVIV, Israel, Sept. 22, 2020 /PRNewswire/ — MedHub, a med-tech company that is leveraging AI to help interventional cardiologists make better decisions, announced today that its AutoCathFFR system has been certified to bear the CE Mark, signifying compliance with the European Union’s health and environmental safety regulations. “Following our recent AMAR regulatory approval, the […]

AutocathFFR, the company’s first commercial product, is a transformative cardiac diagnosis system. TEL AVIV, Israel, June 4, 2020 /PRNewswire/ — MedHub Ltd., a medical technology company focused on developing and commercializing AI powered medical solutions that aid in the diagnosis of cardiac disease, announced that is has gained AMAR approval for its […]

TEL-AVIV, Israel, Feb. 20, 2020 /PRNewswire/ — MedHub develops an advanced AI-based solution for interventional cardiologists. AutocathFFR is the only fully workflow-integrated system that enables cardiologists to take better decisions during the diagnostic procedure by providing them with automated image-based stenosis detection and FFR measurement of each captured stenosis. MedHub successfully completed […]

The software company is commencing its pivotal multi-center clinical trial, aimed at demonstrating the efficacy of its ground-breaking product – AutocathFFR TEL AVIV, Israel, Oct. 22, 2019 /PRNewswire/ — MedHub develops decision-support systems for cardiologists that leverage Artificial Intelligence (AI) to guide cardiologists during the diagnostic cardiac angiography process. The fully automated […]